The size of the Global Electroceuticals Market was worth USD 21.6 billion in 2019 and is estimated to be growing at a CAGR of 7.98%, to reach USD 34.7 billion by 2024. Electroceuticals utilize medical devices to modulate the body's neural circuits as an alternative to drug-based intervention.
Electroceuticals, also referred to as bioelectric medicines utilize a combination of molecular medicine, bioengineering, and neuroscience to develop nerve stimulating and sensing technologies to regulate biological processes and disease treatment. It helps to treat diseases like Epilepsy where conventional drugs aren’t effective in tackling it. Epilepsy is directly caused by an electrical malfunction of the brain. This common neurological disease affects more than 50 million people worldwide.
Factors accountable to drive the market are growing geriatric population, increasing financial expenditure on R and D to develop novel and innovative therapies and devices, rise in prevalence of neural diseases among the aging population like Alzheimer’s and Parkinson’s disease and regulatory approvals or new and advanced electroceuticals.
However, factors like the expensive nature of products and low awareness among individuals are the factors hindering the growth of the market.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Product, Type of Devices, Application, End-User, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Cochlear Limited, Sonova Holding AG, LivaNova PLC, Biotronik, Nevro Corporation, Second Sight Medical Products, Inc., and ElectroCore LLC. |
This market research report on Global Electroceuticals Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.
Electroceuticals Market Analysis – By Product:
Electroceuticals Market Analysis – By Type of Devices:
On the basis of devices type, the Implantable devices have held the major share in the market due to the prevalence of neurological diseases while non-implantable devices are expected to grow at a higher CAGR.
Electroceuticals Market Analysis – By Application:
Electroceuticals Market Analysis – By End-Users:
On the basis of end-users, the hospitals segment is expected to account for the largest share of the market in 2018 while, the individual users segment is projected to grow at the highest CAGR in the forecast period.
Regional Analysis:
North America is leading the market regionally, due to the presence of a developed healthcare system as well as the presence of market leaders. The Asia Pacific is expected to grow the fastest owing to its increasing disposable income, growing government initiatives to develop healthcare infrastructure and increasing awareness.
Companies playing a leading role in the Global Electroceuticals Market profiled in this report are:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Implantable Cardioverter Defibrillators
5.1.3 Cardiac Pacemakers
5.1.4 Spinal Cord Stimulators
5.1.5 Cochlear Implants
5.1.6 Deep Brain Stimulators
5.1.7 Transcutaneous Electrical Nerve Stimulators
5.1.8 Vagus Nerve Stimulators
5.1.9 Sacral Nerve Stimulators
5.1.10 Retinal Implants
5.1.11 Other Electrical Stimulators
5.1.12 Y-o-Y Growth Analysis, By Product
5.1.13 Market Attractiveness Analysis, By Product
5.1.14 Market Share Analysis, By Product
5.2 Type of Devices
5.2.1 Introduction
5.2.2 Implantable Electroceutical Devices
5.2.3 Non-Invasive Electroceutical Devices
5.2.4 Y-o-Y Growth Analysis, By Type of Devices
5.2.5 Market Attractiveness Analysis, By Type of Devices
5.2.6 Market Share Analysis, By Type of Devices
5.3 Application
5.3.1 Introduction
5.3.2 Arrhythmia
5.3.3 Chronic Back Pain
5.3.4 Failed Back Syndrome
5.3.5 Ischemia
5.3.6 Sensorineural Hearing Loss
5.3.7 Parkinson’s Disease
5.3.8 Tremor
5.3.9 Alzheimer's disease
5.3.10 Depression
5.3.11 Migraine
5.3.12 Epilepsy
5.3.13 Other Applications
5.3.14 Y-o-Y Growth Analysis, By Application
5.3.15 Market Attractiveness Analysis, By Application
5.3.16 Market Share Analysis, By Application
5.4 End-Users
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Research Institutes
5.4.4 Individual Users
5.4.5 Y-o-Y Growth Analysis, By End-Users
5.4.6 Market Attractiveness Analysis, By End-Users
5.4.7 Market Share Analysis, By End-Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of Devices
6.1.3.4 By Application
6.1.3.5 By End-Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type of Devices
6.1.4.4 By Application
6.1.4.5 By End-Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type of Devices
6.1.5.4 By Application
6.1.5.5 By End-Users
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic plc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 St. Jude Medical, Inc.
8.3 Boston Scientific Corporation
8.4 Cochlear Limited
8.5 Sonova Holding AG
8.6 LivaNova PLC
8.7 Biotronik
8.8 Nevro Corporation
8.9 Second Sight Medical Products, Inc.
8.10 ElectroCore LLC
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
